The University of Chicago Header Logo

Connection

Mary Rinella to Fatty Acid Synthase, Type I

Back to Details
This is a "connection" page, showing publications Mary Rinella has written about Fatty Acid Synthase, Type I.
Mary Rinella
Connection Strength
0.179
Fatty Acid Synthase, Type I
  1. TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial. Gastroenterology. 2021 11; 161(5):1475-1486.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.